The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models

Growth Hormone and IGF Research

Volumn 13, Issue 1, 2003, Pages 44-53

  Guo, Ning ^a   Ye, Jing Jing ^a   Liang, Shu Jian ^a   Mineo, Rosanna ^a,b   Li, Shu Lian ^a   Giannini, Stefano ^a,c   Plymate, Stephan R ^d   Sikes, Robert A ^e   Fujita Yamaguchi, Yoko ^a,f  

^a Beckman Research Institute of City of Hope   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^f TOKAI UNIVERSITY   (Japan)

Author keywords

Antisense; Breast cancer; Cell proliferation; Insulin like growth factor II; Prostate cancer; Ribozyme

Indexed keywords

MESSENGER RNA; MUTANT PROTEIN; RIBOZYME; SOMATOMEDIN B; VIRUS T ANTIGEN;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER MODEL; CARCINOGENICITY; CELL DEATH; CONTROLLED STUDY; ENZYME SPECIFICITY; EPITHELIUM CELL; GENE EXPRESSION SYSTEM; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR CLONING; NUCLEIC ACID PROBE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

EID: 0037292502     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(02)00121-1     Document Type: Article

References (32)

1. J.M. Chan, M.J. Stampfer, E. Giovannucci, P.H. Gann, J. Ma, P. Wilkinson, C.H. Hennekens, M. Pollak, Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study, 279 (1998) 563-566.
2. H.M. Khandwala, I.E. McCutcheon, A. Flyvbjerg, K.E. Friend, The effects of insulin-like growth factors on tumorigenesis and neoplastic growth, Endocr. Rev. 21 (2000) 215-244.
3. J.A. Figueroa, A.V. Lee, J. Jackson, D. Yee, Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine growth loop, J. Clin. Endocrinol. Metab. 80 (1995) 3476-3482.
4. M.K. Tennant, J.B. Thrasher, P.A. Twomey, R.H. Drivdahl, R.S. Birnbaum, S.R. Plymate, Protein and messenger ribonucleic acid (mRNA) for the Type I insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium, J. Clin. Endocrinol. Metab. 81 (1996) 3774-3782.
5. G. Kimura, J. Kasuya, S. Giannini, V. Honda, S. Mohan, M.H. Kawachi, M. Akimoto, Y. Fujita-Yamaguchi, Insulin-like growth factor (IGF) system components in human prostate cancer cell-lines: LNCaP, DU145, and PC-3 cells, J. Int. Urol. 3 (1996) 39-46.
6. W.H. Daughaday, P. Rotwein, Insulin-like growth factors 1 and 2, peptide messenger ribonucleic acid, gene structures and serum and tissue concentrations, Endocrinol. Rev. 10 (1989) 68-91.
7. W.H. Daughaday, The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors, Endocrinology 127 (1990) 1-4.
8. W.H. Daughaday, B. Trivedi, Measurement of derivative of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia, J. Clin. Endocrinol. Metab. 75 (1992) 110-115.
9. T. Enjoh, N. Hizuka, J.F. Perdue, K. Takano, H. Fujiwara, N. Higashihashi, Y. Marumoto, I. Fukuda, K. Sakano, Characterization of new monoclonal antibodies to human Insulin-like growth factor-II and their application in Western immunoblot analysis, J. Clin. Endocrinol. Metab. 77 (1993) 510-517.
10. J.F. Perdue, T.R. LeBon, J. Kato, B. Hampton, Y. Fujita-Yamaguchi, Binding specificities and transducing function of the different molecular weight forms of insulin-like growth factor-II (IGF-II) on IGF-I receptors, Endocrinology 129 (1991) 3101-3108.
11. S.L. Li, H. Goko, Z.D. Xu, G. Kimura, Y. Sun, M.H. Kawachi, T.G. Wilson, S. Wilczynski, Y. Fujita-Yamaguchi, Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors, Cell Tissue Res. 291 (1998) 469-479.
12. J.J. Rossi, Ribozymes to the rescue: repairing genetically defective mRNAs, Trends Genet. 14 (1998) 295-298.
13. Z.D. Xu, L. Oey, S. Mohan, M.H. Kawachi, N.-S. Lee, J.J. Rossi, Y. Fujita-Yamaguchi, Hammerhead ribozyme-mediated cleavage of the human insulin-like growth factor-II RNA in vitro and in prostate cancer cells, Endocrinology 140 (1999) 2134-2144.
14. V.L. Bae, C.K. Jackson-Cook, A.R. Brothman, S.J. Maygarden, J.L. Ware, Tumorigenicity of SV40T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expression, Int. J. Cancer 58 (1994) 721-729.
15. V.L. Bae, C.K. Jackson-Cook, A.R. Brothman, S.J. Maygarden, S.R. Plymate, J. Chen, J.L. Ware, Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line, Prostate 34 (1998) 275-282.
16. G.N. Thalmann, P.E. Anezinis, S.M. Chang, H.E. Zhau, E.E. Kim, V.L. Hopwood, S. Pathak, A.C. von Eschenbach, L.W. Chung, Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer, Cancer Res. 54 (1994) 2577-2581.
17. G.N. Thalmann, R.A. Sikes, T.T. Wu, A. Degeorges, S.M. Chang, M. Ozen, S. Pathak, L.W. Chung, LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis, Prostate 44 (2000) 91-103.
18. S.L. Li, S.J. Liang, N. Guo, A.M. Wu, Y. Fujita-Yamaguchi, Single chain antibodies against human insulin-like growth factor-I receptor: expression, purification, and effect on tumor growth, Cancer Immunol. Immunother. 49 (2000) 243-252.
19. O.M. El-Badry, L.J. Helman, J. Chatten, S.M. Steinberg, A.E. Evans, M.A. Israel, Insulin-like growth factor II-mediated proliferation of human neuroblastoma, J. Clin. Invest. 87 (1991) 648-657.
20. P. Chomczynski, N. Sacchi, Single-step method of RNA isolation by acid guanidinium, thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162 (1987) 156-159.
21. J.K. Yee, A. Miyanohara, P. LaPorte, K. Bouic, J.C. Burns, T. Friedmann, A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes, Proc. Natl. Acad. Sci. USA 91 (1994) 9564-9568.
22. E. Fichera, S.J. Liang, Z.D. Xu, N. Guo, R. Mineo, Y. Fujita-Yamaguchi, A quantitative reverse transcription and polymerase chain reaction assay reveals increased expression of human insulin-like growth factor-II mRNA in some cancerous breast, bladder, and prostate tissues, Growth Hormone IGF Res. 10 (2000) 61-70.
23. R. Birnbaum, J. Ware, S. Plymate, Insulin-like growth factor-binding protein-3 expression and secretion by cultures of human prostate epithelial cells and stromal fibroblasts, J. Endocrinol. 141 (1994) 342-351.
24. Z.D. Xu, IGF-II expression in human tumor tissues and human IGF-II ribozyme, Dissertation, Loma Linda University, Loma Linda, 1998, pp. 165-166.
25. C.K. Osborne, E.B. Coronado, L.J. Kitten, C.I. Arteaga, S.A.W. Fuqua, K. Rasmasharma, M. Marchall, C.H. Li, Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor, Mol. Endocrinol. 3 (1989) 1701-1709.
26. C. Giani, K.J. Cullen, D. Campani, A. Rasmussen, IGF-II mRNA and protein are expressed in the stroma, of invasive breast cancers: an in situ hybridization and immunohistochemistry study, Breast Cancer Res. Treat. 41 (1996) 43-50.
27. K.J. Cullen, M.E. Lippman, D. Chow, S. Hill, N. Rosen, J.A. Zwiebel, Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression, Mol. Endocrinol. 6 (1992) 91-100.
28. R.J. Daly, W.H. Harris, D.Y. Wang, P.D. Darbre, Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells, Cell Growth Diff. 2 (1991) 457-464.
29. C.L. Arteaga, L.-J. Kitten, E.B. Coronado, S. Jacobs, F.C. Kull Jr., D.C. Allred, C.K. Osborne, Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice, J. Clin. Invest. 84 (1989) 1418-1423.
30. S. Neuenschwander, C.T. Roberts Jr., D. LeRoith, Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth Factor I receptor antisense ribonucleic acid, Endocrinology 136 (1995) 4298-4303.
31. S.R. Plymate, J.L. Ware, M. Tennant, J.B. Thrasher, K. Chatta, R.S. Birnbaum, Transformation and immortalization of human prostate epithelial cells alters responsiveness to IGF-I and IGF binding protein expression and secretion, J. Clin. Endocrinol. Metab. 81 (1996) 3709-3716.
32. P.J. Kaplan, S. Mohan, P. Cohen, B.A. Foster, N.M. Greenberg, The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model, Cancer Res. 59 (1999) 2203-2209.